
Ketone bodies and their potential as biomarkers in relapsed/refractory diffuse large B-cell lymphoma
New Findings in DLBCL Research Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma.
Discover the most recent news about our Company.

New Findings in DLBCL Research Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma.

Obesity, a complex and multifactorial disease, currently affects more than 13% of adults worldwide, according to the latest

We Drive Our International Expansion with the Support of ACCIÓ At Biosfer Teslab, we continue to expand our international presence

Nuclear magnetic resonance (NMR) is an advanced technology that allows the analysis of various biological matrices, from blood

The XXVI Jornadas of XULA (Xarxa d’Unitats de Lípids i Arteriosclerosi) are much more than just a scientific

Metabolomics has emerged in recent years as a powerful tool for the comprehensive assessment of biochemical changes occurring

This year, the Food and Agriculture Organization of the United Nations (FAO) has chosen the theme “The Right to Food

Data analysis has become a fundamental pillar for decision-making in healthcare. As the volume and complexity of clinical, genetic, epidemiological,

Today, on International Familial Hypercholesterolemia (FH) Day, we want to highlight this genetic condition that affects millions of people worldwide

Metabolomics is becoming a crucial tool in biomedical research. By analyzing the complete set of metabolites present in a biological

A recent study led by Dr. David Benaiges (1,2,3,4,5) from the Bariatric Surgery Unit at Hospital del Mar, in collaboration

The integration of metabolomics into clinical trials is revolutionizing medical research by providing detailed insights into the biochemical changes associated